L-Carnitine for Chronic Fatigue Syndrome (ME/CFS)

L-carnitine improved fatigue scores in early chronic fatigue trials, but the evidence is old, small and largely unreplicated.

Overview

L-carnitine improved fatigue scores in early chronic fatigue trials, but the evidence is old, small and largely unreplicated.

Verdict

Mixed evidence

How It Works

Carnitine transports long-chain fatty acids into mitochondria for beta-oxidation; low muscle carnitine has been reported in some CFS patients, suggesting an energy-substrate bottleneck.

Dosing & Protocol

Typical dose

Recommended dose: 500-2000mg daily in divided doses
Expected timeframe: 8 weeks before judging; the trials reporting benefit measured change at 8-12 weeks and effects were gradual.

Protocol

form: Acetyl-L-carnitine for the cognitive-fatigue studies, or plain L-carnitine tartrate
duration: 8-12 weeks, matching trial length; stop if fatigue scores are unchanged
co factor: Take with meals to limit nausea. Crucially, pace activity — post-exertional malaise means graded exercise can worsen ME/CFS, and no supplement changes that
titration: Increase over 2-3 weeks to 1-2 g daily in divided doses; trials used up to 2 g daily and acetyl-L-carnitine 2 g daily was the form in the most-cited study
starting dose: 500 mg twice daily with food (1 g total)

Evidence

What the studies say

A 1997 crossover trial found L-carnitine outperformed amantadine on fatigue measures, and acetyl-L-carnitine showed benefit in a later comparative study. No modern placebo-controlled trial has confirmed these findings.

No studies are yet linked to both L-Carnitine and Chronic Fatigue Syndrome (ME/CFS).

Safety

Caveats

Evidence is mixed and comes from small, mostly unblinded trials with heterogeneous ME/CFS definitions. Common side effects are nausea, cramps and a fishy body odour at higher doses. L-carnitine is converted by gut bacteria to TMAO, whose cardiovascular relevance is debated. It can raise INR with warfarin, and caution applies in seizure disorders, hypothyroidism and dialysis-dependent kidney disease. Data in pregnancy are limited.

Less likely to help if

People whose fatigue is driven by untreated sleep apnoea, depression, hypothyroidism, anaemia or long COVID with orthostatic intolerance, and those with severe ME/CFS who cannot tolerate any increase in activity.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.